{"disease":{"id":"fatty-acid-oxidation-defects","name":"fatty acid oxidation defects"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03728777","title":"Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03531554","title":"Acute Nutritional Ketosis in VLCAD Deficiency","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University Medical Center Groningen","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}